key: cord-0857882-ebsxmc3r authors: Duarte-Casar, Rodrigo; Romero-Benavides, Juan Carlos title: Tragia L. Genus: Ethnopharmacological Use, Phytochemical Composition and Biological Activity date: 2021-12-10 journal: Plants (Basel) DOI: 10.3390/plants10122717 sha: 20580927e8a5f899770afca020873d2f402741c9 doc_id: 857882 cord_uid: ebsxmc3r Tragia L. is a genus of plants belonging to the Euphorbiaceae family with worldwide intertropical distribution, composed of more than 150 species. In this literature review, 26 species of the genus used as medicinal plants were found, mainly in East Africa and the Indian subcontinent, with a variety of uses among which antibacterial, anti-inflammatory, anticancer and reproductive health are most common. Research has been done on a few of the species, mostly those of the Old World, with emphasis on four of them: Tragia involucrata Linn., Tragia spathulata Benth., Tragia benthamii Baker and Tragia plukenetii Radcl.-Sm., confirming several ethnomedicinal claims. Moreover, a variety of active phytochemicals have been isolated, mainly ethers, hydrocarbons, flavonoids and sterols. There is ample field for the evaluation of the activity of Tragia extracts and essential oils and the identification of their active compounds, particularly of the New World species, for which there is still very little research. Plants have been used as a source of medicinal substances for a long time, with a use that amply predates history and presumably even mankind [1] [2] [3] , and the discovery of active species and their use has historically been characterized by a trial-and-error approach [4] . This empirical knowledge has been and is being alidated by systematic research and is used as a guideline to direct the search for better and new drugs, integrating ancestral knowledge and modern methods [5] . Among the plant families considered medicinal, Euphorbiaceae is well regarded. The ample geographical distribution of the family and the variety of stress conditions the plants grow in, which trigger the production of secondary metabolites [6] , partially explain the abundance and variety of biologically active compounds found in the family and thus its medicinal activity [7, 8] . This review endeavors to summarize the current knowledge about species of the Tragia genus, which belongs to the Euphorbiaceae family, concerning their medicinal properties, phytochemical basis, and in vitro and in vivo evidence and envisioning future research prospects. The genus Tragia is one of the 317 genera in the Euphorbiaceae family. There are 161 accepted names belonging to 154 species in the Tragia genus, with "pantropical and warm temperate distribution" [9, 10] . The etymology for the name of this genus comes from the Greek tragos, meaning goat. This name may stem either from the name of the German botanist Hieronymus Bock-Bock means "ram" or "he-goat" in German, or from the hairy appearance of the plant that would resemble a male goat [11] . Species belonging to Euphorbiaceae in general and to Tragia in particular are still not fully settled [8] , as new species are being discovered [15] and species are being reassigned to other genera [9, 16] , so the number of species in the genus is still subject to change. Species belonging to the Tragia genus are present in subtropical America, Eastern and Southern Africa, the Indian subcontinent and Northeastern Australia. Of the 154 species listed in the genus [17] , 94 are found in Africa, 48 in America, 10 in Asia and 3 in Oceania, with some species such as T. arabica and T. plukenetii present both in Africa and Asia. The map in Figure 2 shows the intertropical distribution of Tragia species by country. Species belonging to Euphorbiaceae in general and to Tragia in particular are still not fully settled [8] , as new species are being discovered [15] and species are being reassigned to other genera [9, 16] , so the number of species in the genus is still subject to change. Species belonging to the Tragia genus are present in subtropical America, Eastern and Southern Africa, the Indian subcontinent and Northeastern Australia. Of the 154 species listed in the genus [17] , 94 are found in Africa, 48 in America, 10 in Asia and 3 in Oceania, with some species such as T. arabica and T. plukenetii present both in Africa and Asia. The map in Figure 2 shows the intertropical distribution of Tragia species by country. Published works (articles and patents) were searched on scientific databases-Science Direct, Google Scholar and Scopus-for each species of the genus, using inverted commas for an exact match, e.g., "Tragia acalyphoides". Relevant articles were selected Published works (articles and patents) were searched on scientific databases-Science Direct, Google Scholar and Scopus-for each species of the genus, using inverted commas for an exact match, e.g., "Tragia acalyphoides". Relevant articles were selected after removing search terms unrelated to the area of interest such as corrosion, reforestation or hare diet. When abundant results were obtained, the search was refined with more specific terms, for example "Tragia involucrata medicinal" or "Tragia involucrata ethnopharmacology". Duplicate articles were removed, and the remaining articles were reviewed with a focus on ethnopharmacological uses, phytochemical composition and biological activity, both in vitro and in vivo. When possible, the latest articles, no older than 10 years, have been cited. Preprints were not included. The research interest in Tragia species in medical and health sciences has increased during the last twenty years. Figure 3 shows the number of publications that include the word Tragia in their text in the fields mentioned. Even though the subject is not a very popular one, a steady increase in appearances can be seen, with a marked increase between 2019 and 2020 and the first half of 2021. sciences. Data source: [18] . Compared to the other genera in the Plukenieteae tribe, Tragia concentrates 67% of t research, compared to 12% for Cnesmone, 10% for Acidoton, 4% for Sphaerostylis and 1 each for Megistostigma, Pachystylidium, Platygyna and Tragiella [18] . Of the more than 150 species of the genus, few appear in the scientific literature, an even fewer are mentioned from an ethnopharmacological perspective. Notwithstandin Tragia species are a part of traditional medicinal systems of East Africa and the Indi subcontinent, such as Siddha and Ayurveda [19] , with documented uses of T. involucra appearing as early as the 1st century CE [20] and with only a handful of mentions of Trag species in the New World pharmacopoeia, concerning mostly topical applications. The is concern over an excessive use of Tragia species, e.g., Tragia bicolor, which poses a co servation hazard [21, 22] . Compared to the other genera in the Plukenieteae tribe, Tragia concentrates 67% of the research, compared to 12% for Cnesmone, 10% for Acidoton, 4% for Sphaerostylis and 1% each for Megistostigma, Pachystylidium, Platygyna and Tragiella [18] . Of the more than 150 species of the genus, few appear in the scientific literature, and even fewer are mentioned from an ethnopharmacological perspective. Notwithstanding, Tragia species are a part of traditional medicinal systems of East Africa and the Indian subcontinent, such as Siddha and Ayurveda [19] , with documented uses of T. involucrata appearing as early as the 1st century CE [20] and with only a handful of mentions of Tragia species in the New World pharmacopoeia, concerning mostly topical applications. There is concern over an excessive use of Tragia species, e.g., Tragia bicolor, which poses a conservation hazard [21, 22] . Most of the interest in this genus has been focused on four species: Tragia involucrata, Tragia spathulata, Tragia plukenetii and Tragia benthamii [23] , with the bulk of the research focused on T. involucrata. Nevertheless, several more species and their medicinal uses appear in literature. Table 1 summarizes the species with reported medicinal use along with their stated ethnopharmacological uses, when available. The Anatomical Therapeutic Chemical (ATC) Classification by the World Health Organization (WHO) is used to classify the uses for each species [24] . Figure 4 shows the geographical distribution of the documented uses. The ethnomedical uses of Tragia spp are most abundant in the Indian subcontinent and East and Southern Africa. NS: not specified. ATC categories are as follows. A: alimentary tract and metabolism, B: blood and blood-forming organs, C: cardiovascular system, D: dermatological, G: genitourinary system and sex hormones, H: systemic hormonal preparations, excluding sex hormones and insulins, J: anti-infective for systemic use, L: antineoplastic and immunomodulating agents, M: musculo-skeletal system, N: nervous system, P: antiparasitic products, insecticides and repellents; R: respiratory system, S: sensory organs; V: various [24] , not present in the classification. STDs: sexually transmitted diseases. According to the ATC classification, the most frequent ethnopharmacological uses of Tragia spp. in ethnopharmacology are: genitourinary system and sex hormones, with 19% of occurrences (15 of 77); nervous system, with 12%; and alimentary tract and metabolism, anti-infective for systemic use and antineoplastic and immunomodulating agents with 10% of occurrences each. The "various" classification presents 17% of occurrences, which include non-specified and vague uses, such as "toxic" or "medicinal". As for the morphological structures used per species, the most common are the leaves, 38%; followed by "not specified", 33%; whole plant, 15%; roots, 13% and a single occurrence of endophytes (3%). Biological activity tests of Tragia, both in vitro and in vivo, are performed mostly with plant extracts and to a much lesser degree with essential oils: leaf, root or the whole plant, although ethnopharmacological uses mostly employ the plant via infusions, decoctions or ashes [23, 35] . Different solvents and solvent mixtures have been used for the extracts, mainly methanol and ethanol. Due to the presence of Tragia in ethnomedical traditions in Africa and Asia, there is a team of research about the bioactivity of Old World Tragia extracts that have confirmed their activity and potency in some cases. Not all the health claims or traditional uses recorded have been validated through research. Again, the bulk of the research is centered on T. involucrata. Extracts of T. benthamii, T. brevipes, T. involucrata, T. pungens and T. spatulatha have been tested to ascertain their in vitro activity for a variety of uses. The in vitro research is summarized in Figure 5 . Extracts of T. benthamii, T. brevipes, T. involucrata, T. pungens and T. spatulatha have been tested to ascertain their in vitro activity for a variety of uses. The in vitro research is summarized in Figure 5 . Cases in which the efficacy has been shown in vitro are listed in Table 2 . Cases in which the efficacy has been shown in vitro are listed in Table 2 . In vitro biological activity tests devote the most attention to leaves (36%), with whole plant and root used to a lesser extent, with both 14%. Extraction solvents are methanol (47%), DCM (5%), Ethyl acetate (10%), water (6%), chloroform (5%), petroleum ether (5%), ethanol (5%) and acetone (5%). This solvent usage supports the assumption that most active compounds are moderately polar and are thus extracted with polar solvents. Testing centers on antibacterial (41%) and antifungal (18%) activity of the extracts, with antiproliferative (12%) and antidiabetic, antiurolithiatic, radioprotective, immunomodulatory and cytotoxic effects (6% each) behind. This is a different profile than what was found in the ethnomedicinal claims, which centers on the genitourinary system and sex hormones. This is justified because aphrodisiacs do not have the expected properties [92] . Besides in vitro activity testing, research has been done in animal models, mostly mice and also chicks, with at least one clinical trial performed in humans. The Tragia extracts evaluated in vivo, summarized in Figure 6 and Table 3 , are obtained from four species: T. benthamii, T. furialis, T. involucrata and T. plukenetii. In vitro biological activity tests devote the most attention to leaves (36%), with whole plant and root used to a lesser extent, with both 14%. Extraction solvents are methanol (47%), DCM (5%), Ethyl acetate (10%), water (6%), chloroform (5%), petroleum ether (5%), ethanol (5%) and acetone (5%). This solvent usage supports the assumption that most active compounds are moderately polar and are thus extracted with polar solvents. Testing centers on antibacterial (41%) and antifungal (18%) activity of the extracts, with antiproliferative (12%) and antidiabetic, antiurolithiatic, radioprotective, immunomodulatory and cytotoxic effects (6% each) behind. This is a different profile than what was found in the ethnomedicinal claims, which centers on the genitourinary system and sex hormones. This is justified because aphrodisiacs do not have the expected properties [92] . Besides in vitro activity testing, research has been done in animal models, mostly mice and also chicks, with at least one clinical trial performed in humans. The Tragia extracts evaluated in vivo, summarized in Figure 6 and Table 3 , are obtained from four species: T. benthamii, T. furialis, T. involucrata and T. plukenetii. Most of the research (73%) centers on T. involucrata, with T. plukenetii (18%), T. benthamii (9%) and T. furialis (5%) behind. In vivo assay extracts were obtained from leaves (29%), whole plant (25%), root (21%) and aerial parts (8%). Solvents used are methanol (48%), ethanol (26%) and water (13%), which shows that most active compounds are polar and are thus extracted with polar solvents. T. involucrata Root Wistar rats Hepatoprotective +100-300 mg/kg bw. [57] [55] T. involucrata Water Leaf Wistar rats Swiss mice (male) Anti-inflammatory +50-400 mg/kg bw in carrageenan-induced hindpaw edema and cotton pellet granuloma models. [104] T. involucrata Water +NP Leaf Wistar rats (male) Antiurolithiatic +200 mg/kg bw. CaOx stone formation inhibition in ethylene glycol-induced urolithiasis. [90] Ethanol Aerial parts Wistar rats (male) Antihyperglycemic +At an oral dose of 150 and 300 mg/kg bw. Oral glucose tolerance test in alloxan induced diabetic rats. [105] T. plukenetii Ethanol Whole plant Antipyretic Diuretic Antiasthmatic Analgesic Antispasmodic +100 mg/kg bw. +Antipyretic: Brewer's yeast-induced hyperpyrexia method. +Diuretic: in vivo Lipschitz test method. +Antiasthmatic: Isolation of guinea pig ileum preparation; histamine-induced bronchoconstruction. +Analgesic: acetic acid writhing response. +Antispasmodic: studies on isolated rabbit jejunum. [106] T. plukenetii Ethanol Whole plant Swiss albino mice (male) Antitumor +100-300mg/kg bw. Ehrlich ascites carcinoma survivability. Antioxidant parameters increased DD. [107] T. plukenetii Swiss albino mice Anticonvulsant +100 mg/kg bw. Methanol extract against PTZ-induced convulsions. Most of the research (73%) centers on T. involucrata, with T. plukenetii (18%), T. benthamii (9%) and T. furialis (5%) behind. In vivo assay extracts were obtained from leaves (29%), whole plant (25%), root (21%) and aerial parts (8%). Solvents used are methanol (48%), ethanol (26%) and water (13%), which shows that most active compounds are polar and are thus extracted with polar solvents. For both in vitro and in vivo testing, the most common effect is antibacterial and antimicrobial with 22% of the reviewed studies. This is higher than the 10% reported in the ethnopharmacological uses. Effects having to do with cancer prevention and treatmentantiproliferative, antitumor, cytotoxic immunomodulatory and radioprotective-add up to 17% of the reported effects, which makes it the second most frequent use. Analgesic and anti-inflammatory activity is equally reported in 10% of the tests. The findings reported in literature validate several medicinal use cases for Tragia species and dismiss some claims, e.g., T. meyeriana as an antineoplastic [60] . Phytochemical studies allow for the identification, separation and isolation of compounds of interest [109] . Based on phytochemical screenings published in the literature, the main secondary metabolites found in Tragia species extracts are alkaloids, glycosides, flavonoids, and sterols [23, 110] . Some compounds found in plants belonging to the Tragia genus, classified according to their chemical nature, are listed in Table 4 . Where applicable, the biological activity of the identified compound has been mentioned. Identification of the compounds relies heavily on spectroscopic and spectrometric methods [109] , and chromatography retention times and comparison with the literature are also used for tentative identification. Figure 7 shows the structure of some of the compounds identified in Tragia extracts and oils, mentioning their biological activity in bold when reported. As expected in plant extracts, there is a variety of secondary metabolites in the form of terpenoids and flavonoids. Ethers and non-terpenoid hydrocarbons are reported as having antibacterial activity, and they are not in any of the common groups of secondary metabolites. There is more information about the activity of the extracts and essential oils than about the activity of compounds on their own. The recent discovery of anti-inflammatory peptides in Tragia benthamii extracts [93] opens a new area of interest in the research of Tragia species. A strength of the genus is its diversity and its pantropical distribution, which makes it readily available in most tropical countries. A weakness would be that, despite the interest shown concerning T. involucrata and other traditionally medicinal species, there appear to be no drugs derived from plants of these species, remaining in the realm of herbal remedies and plant extracts, entailing less medicinal interest than other genera of the Euphorbiaceae family, notably Euphorbia [8] . This can be attributed to the stage of research, with most work performed in vitro or in vivo and with a single clinical trial [52] . Hopefully the current research will advance into new drugs. and oils, mentioning their biological activity in bold when reported. As expected in plant extracts, there is a variety of secondary metabolites in the form of terpenoids and flavonoids. Ethers and non-terpenoid hydrocarbons are reported as having antibacterial activity, and they are not in any of the common groups of secondary metabolites. There is more information about the activity of the extracts and essential oils than about the activity of compounds on their own. The recent discovery of anti-inflammatory peptides in Tragia benthamii extracts [93] opens a new area of interest in the research of Tragia species. Species belonging to the Tragia genus are present in traditional medicine in several cultures and have multiple uses, among which antibacterial, anticancer and aphrodisiac are most frequent. There is scientific evidence that supports the use of these species in medicine, both at the extract level and at the active compound level, with in vivo tests in rats and mice, but there are no drugs derived from the species yet. The activity reported most frequently for Tragia extracts is antimicrobial and cancer-related, which suggests further research in those areas. Less than 20% of the Tragia species are considered medicinal. This implies vast potential for screening and discovery of active compounds. Most ethnopharmacological reports come from Asia and Africa, mainly East Africa and the Indian subcontinent. New world Tragia species have not been sufficiently studied and may prove to be a rich source of extracts and phytochemicals for drug research. Future directions for research include nanoparticles, the research into peptides extracted from Tragia species and the validation of medicines containing Tragia extracts against SARS-CoV-2. Importance of Medicinal Plants in Human and Plant Pathology: A Review Medicinal Plants: Past History and Future Perspective Drug Discovery from Plant Sources: An Integrated Approach The Effect of Developmental and Environmental Factors on Secondary Metabolites in Medicinal Plants Importancia Medicinal Del Género Croton (Euphorbiaceae) Why Do Euphorbiaceae Tick as Medicinal Plants? A Review of Euphorbiaceae Family and Its Medicinal Features Euphorbiaceae, Plukenetieae), a New Genus of Tragiinae from the Amazon Rainforest of Venezuela and Brazil Ex L. | Plants of the World Online | Kew Science Oxalates-containing plants Oxalic Acid/Oxalates in Plants: From Self-Defence to Phytoremediation Distribution, Ecology, Chemistry and Toxicology of Plant Stinging Hairs A New Endangered Species of Tragia (Euphorbiaceae) from the Brazilian Atlantic Forest A New Amazonian Genus Segregated from Tragia World Checklist and Bibliography of Euphorbiaceae (and Pandaceae) Digital Science Dimensions Comparative Evaluation of Hypoglycaemic Activity of Some Indian Medicinal Plants in Alloxan Diabetic Rats Ethnopharmacological Use and Biological Activities of Tragia involucrata L. Evid. Based Complement. Altern Bioresources and Bioprocess in Biotechnology Developing an Information System for the Rare Endangered and Threatened (RET) Plants of Southern Western Ghats Pharmacological and Biological Profiles of Tragia Species (Family: Euphorbiaceae) Espécies úteis da família Euphorbiaceae no Brasil Phytochemical Screening, Antimalarial and Histopathological Studies of Allophylus Africanus and Tragia benthamii Filaricidal Activities on Onchocerca Ochengi and Loa Loa, Toxicity and Phytochemical Screening of Extracts of Tragia Benthami and Piper Umbellatum Sexual Prowess from Nature: A Systematic Review of Medicinal Plants Used as Aphrodisiacs and Sexual Dysfunction in Sub-Saharan Africa An Appraisal of Documented Medicinal Plants Used for the Treatment of Cancer in Africa over a Twenty-Year Period Cytotoxic Activity of Medicinal Plants of the Kakamega County (Kenya) against Drug-Sensitive and Multidrug-Resistant Cancer Cells Ethnobotanical Study of Medicinal Plants Used against Human Ailments in Gubalafto District, Northern Ethiopia An Inventory of Medicinal Plants Used to Treat Gynaecological-Obstetric-Urino-Genital Disorders in South Nandi Sub County in Kenya Medicinal Plants Used for the Treatment of Erectile Dysfunction in Ethiopia: A Systematic Review Ethnobotanical Survey and Propagation of Some Endangered Medicinal Plants from South Nandi District of Kenya Global Documentation of Traditionally Used Medicinal Plants in Cancer Management: A Systematic Review An Ethnobotanical Study of Medicinal Plants in Chiro District, West Hararghe Ethnobotanical Study of Medicinal Plants Used to Treat Human Ailments by Guji Oromo Tribes in Abaya District Ethiopian Common Medicinal Plants: Their Parts and Uses in Traditional Medicine-Ecology and Quality Control Ethnobotanical Survey of Plants Used by Bapedi Traditional Healers to Treat Tuberculosis and Its Opportunistic Infections in the Limpopo Province Ethno-Medicinal Study of Plants Used for Treatment of Human and Livestock Ailments by Traditional Healers in South Omo, Southern Ethiopia Ethnobotanical Review of Plants Used for the Management and Treatment of Childhood Diseases and Well-Being in South Africa Screening of Traditionally Used Plants for in Vivo Antimalarial Activity in Mice Ethnomedicine of the Kagera Region, North Western Tanzania. Part 2: The Medicinal Plants Used in Katoro Ward, Bukoba District Ethnobotanical Survey Of Plant Species Used In Traditional Medicine In Bekaraoka Region, Northeastern Madagascar Medicinal Plants: A General Review and a Phytochemical and Ethnopharmacological Screening of the Native Argentine Flora Medicinal Plants from the "Sierra de Comechingones Medicinal Plants in Ethnobotanical and Religious Traditions in Cuba: A First Review and Updating A Glimpse on Forest Flora and Indian System of Medicine Plants of Chitradurga District Medical Formulas for Krimidanta (Dental Caries) in Indigenous Medicine in Sri Lanka-A Literary Review Isolation, Identification and Bioactivity of Fungal Endophytes from Selected Kenyan Medicinal Plants Efficacy and Safety of Freeze-Dried Form of Tragia involucrata L. Decoction in Treating Diabetes: A Randomized Controlled Clinical Trial Phytochemical Examination and Antimicrobial Activity of Various Solvent Extracts and the Selected Isolated Compounds from Roots of Tragia involucrata Linn Phytochemical and Pharmacological Evaluation of Tragia Cannabina for Anti-Inflammatory Activity Analgesic Activity of Tragia involucrata. Dhaka Univ Evaluation of Diuretic Effect of the Hot Water Extract of Standardized Tragia involucrata Linn., in Rats Hepatoprotective and Antioxidant Activity of Tragia involucrata Root Extracts against CCl4 Induced Hepatotoxicity in Rats A Review on Herbs Used in Treatment of Diabetes Mellitus by Sri Lankan Ayurvedic and Traditional Physicians Unravelling the Names, Origins and Chemistry of "Muthis" Used for Male Sexual Disorders Antineoplastic Constituents of Some Southern African Plants The Immune Effects of an African Traditional Energy Tonic in In Vitro and In Vivo Models. Evid. Based Complement Ethnomedicinal Plant Knowledge and Practice of the Oromo Ethnic Group in Southwestern Ethiopia Medicinal Plants and Their Uses by the People in the Region of Randa, Djibouti Indigenous Knowledge, Major Threats and Conservation Practices of Medicinal Plants by Local Community in Heban Arsi District, Oromia, South Eastern Ethiopia Ethnobotanical Study of Indigenous Knowledge on Medicinal Plant Use by Traditional Healers in Oshikoto Region, Namibia Floristic Diversity and Uses of Medicinal Plants Sold by Street Vendors in Gaborone Plantes magiques et médicinales des Féticheurs de l'Oubangui (Région de Bangui) Ethnobotanical Survey of Medicinal Plants in Central Abyan Governorate Ethiopian Traditional Herbal Drugs. Part III: Anti-Fertility Activity of 70 Medicinal Plants Extraction and Isolation of Clerodane as a Bioactive Molecule from Tragia Ramosa An Inventory and Analysis of the Food Plants of Southern Africa An Inventory of Vhavenda Useful Plants Systematic Review of Plants Used Against Respiratory Diseases Related to COVID-19 in Africa Some Ethnoremedies Used for HIV/AIDS and Related Diseases in Swaziland Antimicrobial Efficacy of the Leaves of Dioclea Reflexa, Mucuna Pruriens, Ficus Asperifolia and Tragia spathulata Medicinal Plants Used by Traditional Medicine Practitioners in the Treatment of Tuberculosis and Related Ailments in Uganda Como Potencial de Plantas Medicinais e Tóxicas Etudes Flor Vég La Hierba de Quetzalcoatl Ethnobotanical Uses of Medicinal Plants of Two Ethnoecological Regions of Cameroon Antibacterial Activities of Fagara Macrophylla, Canarium Schweinfurthii, Myrianthus Arboreus, Dischistocalyx Grandifolius and Tragia benthamii against Multi-Drug Resistant Gram-Negative Bacteria Total Phenolic Content and in Vitro Antiproliferative Activity of Tragia Brevipes (Pax) and Tetradenia Riparia (Hochst) Leaves Extract In Vitro and in Silico Antidiabetic Activity of Pyran Ester Derivative Isolated from Tragia Cannabina. Asian Pac Bioactive Potential of Indian Stinging Plants Leaf Extract against Pathogenic Fungi Evaluation of Aromatic Plants and Compounds Used to Fight Multidrug Resistant Infections Investigation on the Biological Attributes of Tragia involucrata Linn. Using in Vitro Methods Evaluation of in Vitro and in Vivo Anti-Urolithiatic Activity of Silver Nanoparticles Containing Aqueous Leaf Extract of Tragia involucrata Cytotoxicity Based Screening for Radioprotective Properties of Methanolic Extract of Tragia involucrata L. on Cultured Human Peripheral Lymphocytes Exposed to Gamma Radiation Detection of Cysteine-Rich Peptides in Tragia benthamii Baker (Euphorbiaceae) and in Vivo Antiinflammatory Effect in a Chick Model Larvicidal and Oviposition Deterrence Activity of Tragia involucrata L. (Euphorbiaceae) Root Extractives against Vector of Lymphatic Filariasis Culex Quinquefasciatus (Diptera: Culicidae). Asian Pac Evaluation of Nephroprotective and Antioxidant Potential of Tragia involucrata Antitumor Activity of Hexane and Ethyl Acetate Extracts of Tragia involucrata Ethyl Acetate and n-Hexane Extracts of Tragia involucrata L. Leaves Exhibit Anxiolytic, Sedative and Analgesic Activity in Swiss Albino Mice Purification of Antibacterial Agents from Tragia involucrata-A Popular Tribal Medicine for Wound Healing Mitigation of Radiation-Induced Oxidative Stress by Methanolic Extract of Tragia involucrata in Swiss Albino Mice Plants 2021 Preliminary Studies on the Anti-Inflammatory and Analgesic Activity of the Methanolic Fraction of the Root Extract of Tragia involucrata Linn Wound Healing Potential of Tragia involucrata Extract in Rats Effect of Aqueous Extract of Tragia involucrata Linn. on Acute and Subacute Inflammation Antihyperglycemic Effects of Tragia Plukenetii Ethanolic Extract Antitumor and Antioxidant Potential of Tragia Plukenetii R. Smith on Ehrlich Ascites Carcinoma in Mice Evaluation of Anticonvulsant Activity of Tragia Plukenetii R. Smith Leaf Extracts against Chemoshock Induced by Pentylenetetrazole in Mice Phytochemicals: Extraction, Isolation, and Identification of Bioactive Compounds from Plant Extracts Qualitative Analysis of Phytoconstituents in Tragia Brevipes Plant Phytochemical and Spectral Study of the Medicinal Plant: Tragia Plukenetii Chemical Compositions and Radical Scavenging Potentials of Essential Oils from Tragia benthamii (BAKER) and Cissus Aralioides (WELW) Screening of Wild Plant Species for Antibacterial Activity and Phytochemical Analysis of Tragia involucrata L Isolation of 2, 5-Dithia-3, 6-Diazabicyclo [2.2.1] Heptane and GC-MS Analysis of Silylated Extract from Tragia benthamii Antihistamine from Tragia involucrata L. Leaves We are grateful to Natalia Bailón-Moscoso for her many valuable suggestions that improved this work. We are also grateful to the Universidad Técnica Particular de Loja (UTPL) for supporting this research and open access publication. The authors declare no conflict of interest.